We’re proud to be part of this year’s WVC, working together with our colleagues and partners in the industry to prepare for future pandemics and enable faster and more effective virus vaccine developments. We are committed to providing solutions to the greatest challenges in laboratory testing for vaccines today and tomorrow, constantly setting the standards to protect the world against infectious disease.
Business Development Manager, Cerba Research
Presentation Title: Assay Development Advances in hMPV and PIV-3 Vaccine Research
Date: Wednesday April 23, 2025 |14:40
Track/Stream: Emerging and Re-Emerging Diseases | Level 2, Room 202B
We look forward to connecting with industry colleagues at Booth 421. Stop by to meet our experts, learn about our virology capabilities, and join us for a chat during cocktail hour—exclusive invitations available at the booth
ViE Nominations – Best Central/Specialty Laboratory Award 2025
We are thrilled to announce our nomination at the ViE awards for 2025. We are proud to be recognized in this prestigious program, which highlights excellence in the global vaccine industry.
We deliver exceptional operational expertise, customized logistical services for sample and kit management, and scientific precision to address the evolving challenges of emerging infectious diseases. By harnessing the knowledge and experience of our global team, along with the latest technologies, we accelerate clinical trials and work towards alleviating the global impact of infectious diseases, supported by our commitment to innovation, science, and infrastructure.
ID trials since 2018
COVID-19 trials
Trials include specialty testing
Virology center of excellence
Get in touch with us today today to find out how we can support your clinical trials laboratory ambitions
